GlassScriptPhysician profile
Ryan T Deci
NPI 1710484514
$1,670.99
in general payments reported to CMS, 2019-2025
5 companies · $159 in 2025
The $159 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,512 · 2025: $159.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,334 · Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,334.10 |
| Food and Beverage | $336.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,492.73 | 2024-2025 | Advantagerib, Ribfix Blu Advantage |
| Conmed Corporation | $119.20 | 2024 | Airseal |
| Avita Medical Americas, LLC | $22.80 | 2025 | Recell, Permeaderm, Cohealyx |
| Merck Sharp & Dohme LLC | $21.61 | 2025 | Zerbaxa |
| Vertex Pharmaceuticals Incorporated | $14.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Deci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.